X0306 4 2017-03-22 1 0000885306 CYNOSURE INC CYNO 0001328980 Hatsopoulos Marina C/O CYNOSURE, INC. 5 CARLISLE ROAD WESTFORD MA 01886 1 0 0 0 Class A Common Stock 2017-03-22 4 U 0 18850 66.00 D 0 D Stock Option (right to purchase) 8.40 2017-03-22 4 D 0 5000 D 2018-11-14 Class A Common Stock 5000 0 D Stock Option (right to purchase) 7.24 2017-03-22 4 D 0 6000 D 2019-05-13 Class A Common Stock 6000 0 D Stock Option (right to purchase) 13.60 2017-03-22 4 D 0 6000 D 2020-05-12 Class A Common Stock 6000 0 D Stock Option (right to purchase) 13.97 2017-03-22 4 D 0 6000 D 2021-05-12 Class A Common Stock 6000 0 D Stock Option (right to purchase) 11.89 2017-03-22 4 D 0 2000 D 2021-07-27 Class A Common Stock 2000 0 D Stock Option (right to purchase) 21.16 2017-03-22 4 D 0 8000 D 2022-05-09 Class A Common Stock 8000 0 D Stock Option (right to purchase) 23.45 2017-03-22 4 D 0 8000 D 2023-06-24 Class A Common Stock 8000 0 D Stock Option (right to purchase) 21.11 2017-03-22 4 D 0 10648 D 2024-05-14 Class A Common Stock 10648 0 D Stock Option (right to purchase) 35.37 2017-03-22 4 D 0 5244 D 2025-05-14 Class A Common Stock 5244 0 D Restricted Stock Units 2017-03-22 4 D 0 1272 D 2026-05-11 Class A Common Stock 1272 0 D Pursuant to the terms of that certain Agreement and Plan of Merger, dated as of February 14, 2017, by and among Hologic, Inc., Minuteman Merger Sub, Inc. and Cynosure, Inc. (the "Merger Agreement"), these shares were tendered and disposed of at the Acceptance Time (all terms capitalized but not defined shall have the meaning given to them in the Merger Agreement) in exchange for the right to receive $66.00 per share, net to the seller in cash, without interest, less any required withholding taxes (the "Merger Consideration"). This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each outstanding and unexercised stock option as of immediately prior to the Effective Time, whether vested or unvested, was automatically canceled and converted into the right to receive, for each underlying share, the difference between the Merger Consideration and the exercise price per share of the option. Each restricted stock unit represents a contingent right to receive one share of Cynosure, Inc.'s common stock. Pursuant to the terms of the Merger Agreement, each outstanding and unvested restricted stock unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. /s/ Christopher J. Geberth, Attorney-in-Fact 2017-03-24